ScriptSave WellRx partners with SinfoniaRx to enhance patient experience with no-cost, convenient access to licensed medical professionals
New York, NY. February 06, 2018 – ScriptSave® WellRx, a prescription savings website and mobile app, and SinfoníaRx, a subsidiary of Tabula Rasa HealthCare (NASDAQ:THRC), a technology company optimizing medical safety through proprietary software solutions and decision support tools, have announced a partnership that will make Medication Therapy Management (MTM) available by phone at no cost to consumers who use the ScriptSave WellRx website or app.
Medication Therapy Management (MTM) programs allow pharmacists to interact directly with patients to optimize the effectiveness and safety of their medication regimens. MTM helps to ensure patients follow their prescription drug regimens through enhanced communications, leading to fewer adverse drug events (ADEs) and overall improved health outcomes.
“Rising costs for prescription medications, combined with the increasing number of health benefit designs that include higher out-of-pocket spend, have placed a bigger financial burden on the patient,” said Marcus Sredzinski, PharmD and Chief Operating Officer of ScriptSave WellRx. “This financial hardship can lead to poor medication adherence and compliance. We are excited to offer ScriptSave WellRx as a tool to help consumers stay on their medication therapy for better health outcomes.
“As one of the nation’s premier medication management companies, SinfoníaRx’s pharmacists bring an important component to ScriptSave WellRx, offering medication information to our members if they have a question about drug interaction, dosage or alternatives,” said Sredzinski.
The Need for Medication Therapy Management
Patients frequently leave their doctor’s office only to discover later they have questions about their prescribed medications. Questions about dosage, side effects, alternative options, and payment options are not uncommon. MTM connects patients with pharmacists to address these concerns and enhances a personalized approach to medication management. Under this partnership, SinfoníaRx will provide clinical pharmacists, while the ScriptSave WellRx technology will connect patients with these pharmacists via their free mobile app.
“By partnering with ScriptSave WellRx, we are helping patients use the latest technology to better understand their medication regimen,” said Kevin Boesen, PharmD, CEO of SinfoníaRx. “As pharmacists, we care about optimizing an individual’s medication therapy. This partnership will ultimately help ensure that patients take their medications correctly and stick to their regimen.”
The partnership will give more than half a million ScriptSave WellRx users access to this free customized care. By improving communication and providing important information, programs like the ScriptSave WellRx ‘Ask A Pharmacist’ MTM program with SinfoníaRx can help prevent deaths, needless hospitalization, unnecessary medical bills, and increased strain on America’s healthcare system.
“ScriptSave already offers patients important information and services regarding their prescriptions,” said Sredzinski. “By partnering with SinfoníaRx, our pharmacists will encourage patients to be proactive about their health and get answers about their medications after leaving the doctor’s office and pharmacy.”
About ScriptSave WellRx
ScriptSave WellRx, owned by parent company Medical Security Card Company, LLC (MSC) and a member of the MedImpact, Inc. family of companies, offers savings on prescription medicines at more than 62,000 local and chain pharmacies, nationwide. ScriptSave WellRx is an online resource that makes prescription medicines more affordable and easier to manage for people who are uninsured, underinsured, or insured with high deductible plans.
About TRHC and SinfoníaRx
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. SinfoníaRx is a Tabula Rasa HealthCare company. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Stratification and/or Medication Therapy Management under the new scope of work. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2017, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website https://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.